HK$23.98
2.92%
Hong Kong, Sep 25, 03:45 pm HKT. Closed.
ISIN
KYG3887G1091
Symbol
2367

Giant Biogene Holding Co Stock price

HK$24.04
-3.08 11.36% 1M
-4.98 17.15% 6M
-8.39 25.86% YTD
-28.28 54.05% 1Y
-8.19 25.42% 3Y
-1.42 5.59% 5Y
-1.42 5.59% 10Y
-1.42 5.59% 20Y
Hong Kong, Closing price Fri, Sep 25 2026
-0.66 2.67%
ISIN
KYG3887G1091
Symbol
2367

Is Giant Biogene Holding Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$25.9b
Enterprise Value
HK$17.3b
Net debt
positive
Cash
HK$8.6b
Shares outstanding
1.1b
Valuation (TTM | estimate)
P/E
13.1
P/S
4.2 | 3.5
EV/Sales
2.8 | 2.4
EV/FCF
-
P/B
2.4
Dividends
DPS
HK$1.39
Yield 1Y | 5Y
2.6% | 0.8%
Growth 1Y | 5Y
-3.6% | -
Payout 1Y | 3Y
60.3% | 35.3%
Increased
3 Years
Financials (TTM | estimate)
Revenue
HK$6.2b | HK$7.3b
EBITDA
-
EBIT
HK$2.3b
Net Income
HK$2.0b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-12.9% | 13.5%
EBITDA
-
EBIT
-24.2%
Net Income
-26.0%
Free Cash Flow
-
Margin
Gross
79.1%
EBITDA
-
EBIT
37.2%
Net
31.4%
Free Cash Flow
-
Financial Health
Equity Ratio
91.4%
Return on Equity
19.3%
ROCE
20.9%
ROIC
79.8%
Debt/Equity
0.0
More
EPS
HK$1.8
FCF per Share
-
Short interest
-
Employees
2k
Rev per Employee
HK$2.9m

Giant Biogene Holding Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Giant Biogene Holding Co forecast:

23x Buy
82%
5x Hold
18%

Analyst Opinions

28 Analysts have issued a Giant Biogene Holding Co forecast:

Buy
82%
Hold
18%

Financial data from Giant Biogene Holding Co

Jun '26
+/-
%
6,220 6,220
13% 13%
100%
- Direct Costs 1,302 1,302
0% 0%
21%
4,918 4,918
16% 16%
79%
- Selling and Administrative Expenses 2,839 2,839
4% 4%
46%
- Research and Development Expense 109 109
6% 6%
2%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2,315 2,315
24% 24%
37%
Net Profit 1,954 1,954
26% 26%
31%

In millions HKD.

Don't miss a Thing! We will send you all news about Giant Biogene Holding Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Giant Biogene Holding Co. Ltd. is an investment company, which engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products. The company is headquartered in Xi'An, Shaanxi and currently employs 2,162 full-time employees. The company went IPO on 2022-11-04. The firm's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The firm primarily conducts its businesses in domestic market.

Head office Cayman Islands
CEO Mr. Yan
Employees 2,201
Website www.xajuzi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today